Apr11_Article
April 11, 2025

NexThera, Oculis and Bayer Report Advances in Retinal Disease Therapies

Eye drops and fewer shots: NexThera, Oculis and Bayer move the needle in retinal disease care. NexThera, Bayer and Oculis…

Website thumbnail FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes Related Blindness (1)
February 5, 2025

FDA Approves the First Anti-VEGF Port Delivery System for Diabetic Macular Edema

Got a patient with DME? Say goodbye to the monthly jab—Susvimo, the first continuous drug delivery system for DME just…

Discover our fascinating content at issuu

explore